Why the study?
Patients with heart failure with concomitant ischemic heart disease have not been well characterized.
Does elevated troponin, prior MI, or angina predict mortality in patients presenting with acute ischemic heart failure?
Does elevated troponin, prior MI, or angina predict mortality in patients presenting with acute ischemic heart failure?
In patients with acute heart failure, elevated troponin is a significant predictor of 30-day and 1-year mortality, whereas prior MI or angina are not.
Elevated troponin may aid short- and long-term risk stratification in acute HF; leaves open mechanisms independent of prior ischemic disease.
BACKGROUND: Patients with heart failure (HF) with concomitant ischemic heart disease (IHD) have not been well characterized. We examined survival of patients with ischemic HF syndrome (IHFS), defined as presentation with acute HF and concomitant features suggestive of IHD. METHODS: Patients were included if they presented with acute HF to hospitals in Ontario, Canada. IHD was defined by any of the following criteria: angina/chest pain, prior myocardial infarction (MI), or troponin elevation that was above the upper limit of normal (mild) or suggestive of cardiac injury. Deaths were determined after hospital presentation. RESULTS: interaction = 0.588). After multivariable adjustment, prior MI and angina were not associated with higher mortality risk. CONCLUSIONS: In acute HF, elevated troponin, but not prior MI or angina, was associated with a higher risk of 30-day and 1-year mortality irrespective of left ventricular ejection fraction.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: